recombinant human granulocyte colony-stimulating factors
Showing 1 - 25 of >10,000
Granulocyte Colony-stimulating Factor, Stem Cell Mobilization Trial (PEG-rhG-CSF)
Not yet recruiting
- Granulocyte Colony-stimulating Factor
- Stem Cell Mobilization
- (no location specified)
Jun 13, 2022
Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)
Recruiting
- Lymphoma
- Multiple Myeloma
- pegylated recombinant human granulocyte-colony stimulating factor
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Sep 23, 2023
Pediatric Cancer Trial in Guangzhou (pegylated recombinant human granulocyte-colony stimulating factor)
Recruiting
- Pediatric Cancer
- pegylated recombinant human granulocyte-colony stimulating factor
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center,
Aug 27, 2021
Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)
Recruiting
- Neuroblastoma
- Naxitamab monotherapy
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 31, 2023
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Radiotherapy
- +4 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023
Anterior Myocardial Infarction, Heart Failure Trial in Rome (rhu G-CSF, optimal standard of care, Myocardial Contrast
Withdrawn
- Anterior Myocardial Infarction
- Heart Failure
- rhu G-CSF
- +2 more
-
Rome, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli
Mar 28, 2022
Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2b, Zidovudine, Sargramostim)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon alfa-2b
- +2 more
-
New York, New YorkMem Sloan - Kettering Cancer Ctr
Oct 26, 2021
Breast Cancer Trial in Nanjing (Day 7 regimen, Day 3 regimen)
Recruiting
- Breast Cancer
- Day 7 regimen
- Day 3 regimen
-
Nanjing, Jiangsu, Chinathe First Affiliated Hospital of Nanjing Medical University
Jul 17, 2021
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Thymalfasin
- +3 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Mar 29, 2023
Acute Myeloid Leukemia, in Relapsed or Refractory, Acute Myeloid Leukemia, Elderly, Unfit, Acute Myeloid Leukemia With Positive
Unknown status
- Acute Myeloid Leukemia, in Relapsed or Refractory
- +2 more
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Sep 8, 2020
Breast Cancer, Neutropenia Trial in Beijing (PEG-rhG-CSF)
Completed
- Breast Cancer
- Neutropenia
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Oct 26, 2020
Early-stage Breast Cancer Trial in Ottawa (Granulocyte Colony-Stimulating Factor (G-CSF), Omission of Granulocyte
Not yet recruiting
- Early-stage Breast Cancer
- Granulocyte Colony-Stimulating Factor (G-CSF)
- Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
-
Ottawa, Ontario, CanadaThe Ottawa Hospital Cancer Centre
Feb 22, 2023
Poor Graft Function, Stem Cell Transplantation, GVHD Trial in Beijing (infusion of G-CSF mobilized peripheral harvest)
Completed
- Poor Graft Function
- +2 more
- infusion of G-CSF mobilized peripheral harvest
-
Beijing, Beijing, ChinaPeking University Institute of Hematology
Sep 23, 2020
Primary Ovarian Insufficiency, Premature Ovarian Failure Trial in Toronto (Neupogen)
Recruiting
- Primary Ovarian Insufficiency
- Premature Ovarian Failure
-
Toronto, Ontario, CanadaTrio Fertility
Oct 31, 2023
Lymphoma, Leukemia Trial in Shanghai (PEG-rhG-CSF group, rhG-CSF group)
Unknown status
- Lymphoma
- Leukemia
- PEG-rhG-CSF group
- rhG-CSF group
-
Shanghai, ChinaChildren's Hospital of Fudan University
Aug 2, 2020
Alcoholic Hepatitis Trial in Chandigarh (Standard Medical Therapy, G-CSF, G-CSF and NAC)
Completed
- Alcoholic Hepatitis
- Standard Medical Therapy
- +2 more
-
Chandigarh, IndiaDept of Hepatology, PGIMER
Apr 29, 2023
Intrauterine Infusion of GCSF and Reproductive Outcomes in
Recruiting
- Recurrent Implantation Failure
- +2 more
- Granulocyte Colony-Stimulating Factor
- placebo
-
Cairo, AlQuahira, EgyptCairo university Kasr Alainy OBGYN hospital
Jun 8, 2022
Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)
Not yet recruiting
- Lymphoma
-
Changchun, Jilin, ChinaThe First Bethune Hospital of Jilin University
Apr 18, 2023
Acute Myeloid Leukemia Trial in Duarte (procedure, drug, biological, other, radiation)
Recruiting
- Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 8, 2022
Pediatric Cancer, Neutropenia, Lenograstim Trial in Taoyuan (G-CSF administration (bolus injection versus intravenous infusion))
Recruiting
- Pediatric Cancer
- +4 more
- G-CSF administration (bolus injection versus intravenous infusion)
-
Taoyuan, ROC, TaiwanChang Gung Children Hospital
Nov 21, 2023
Granulocyte Colony-Stimulating Factor Trial in Wuhan (PEG-rhG-CSF, G-CSF)
Not yet recruiting
- Granulocyte Colony-Stimulating Factor
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jul 31, 2023
Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)
Completed
- Glioblastoma
- Gliosarcoma
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 4, 2022